4.4 Review

Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review

期刊

出版社

WILEY
DOI: 10.1111/irv.12087

关键词

Vaccination; Medical staff; Influenza; Human; Transmission; Patients; Public health

资金

  1. GlaxoSmithKline (GSK)
  2. F. Hoffmann-La Roche
  3. Astra-Zeneca
  4. European Society for Clinical Microbiology and Infectious Diseases
  5. Baxter AG
  6. GSK
  7. Novartis
  8. Solvay

向作者/读者索取更多资源

Healthcare workers (HCWs) are at increased risk of exposure to respiratory pathogens and may transmit infection to vulnerable patients. This study summarises a recent systematic review, which aimed to assess evidence that influenza or pneumococcal vaccination of HCWs provides indirect protection for those patients most at risk of severe or complicated acute respiratory infection. A number of healthcare databases and sources of grey literature were searched using a predefined strategy, and citations screened for eligibility in accordance with specified inclusion criteria. Risk of bias was assessed using validated tools and results summarised qualitatively. Twenty papers were included in the final review, all of which considered influenza vaccination of HCW. As such, planned subanalysis of pneumococcal vaccination was discarded. The majority of primary research studies included (11/14) were conducted in long-term care facilities, but there was marked heterogeneity in terms of the population, intervention/exposure and outcomes considered. Consistency in the direction of effect was observed across several different outcome measures, suggesting that influenza vaccination of HCWs is likely to offer some protection. Further evidence is, however, required from acute care settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据